PIPELINE

PIPELINE

Philogen is a fully integrated company active in the discovery, GMP production and clinical development of immunomodulatory biopharmaceuticals.
We have a leading position in the field of antibody-based therapeutics specific for markers of angiogenesis; at present we have 4 ‘armed antibodies’ in clinical development in the oncology field and 2 in pre-clinical/clinical development in chronic inflammatory disease. The immunocytokines have proven ability to selectively deliver their immunomodulatory payload at sites of disease.